Novavax shares tumble after U.S. health secretary raises concerns over COVID shot’s efficacy
(Reuters) -Vaccine maker Novavax's shares plunged over 22% on Thursday after Health and Human Services Secretary Robert F. Kennedy Jr. ...
Read moreDetailsTag: Novavax
Novavax’s quarterly loss shrinks as it ramps down spending on COVID vaccines
(Reuters) - Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 vaccines, its only ...
Read moreDetailsNovavax cuts 2024 revenue forecast again on lower COVID vaccine sales
By Patrick Wingrove (Reuters) -Novavax (NVAX) cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ...
Read moreDetails
